Home CNS Celgene Funded Study Finds Incidence of Depression Nearly 100% Higher than Non-MS

Celgene Funded Study Finds Incidence of Depression Nearly 100% Higher than Non-MS

158
0

MD Edge reports Celgene recently funded a study evidencing that patients with multiple sclerosis (MS) have nearly 100% higher incidence of new treated depression, compared with matched patients without MS, according to an analysis of data from patients I the United Kingdom. See the link below for results of this Celgene sponsored study.

Lead Research/Investigator

Neil Minton, MD, drug safety head

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.